GHUCCTS

News

Share This
  • Feb 21, 2020

Monumental clinical trial leverages GHUCCTS Trial Innovation Network

The Memory Improvement through Nicotine Dosing (MIND) study team leveraged the GHUCCTS Trial Innovation Network (TIN) to identify collaborators for the trial through an EHR-based cohort assessment. The clinical trial was placed at the Georgetown University Memory Disorders Program. Investigators also utilized the TIN to conduct community engagement studios that allow for meaningful involvement of diverse groups of stakeholders in the planning and implementation of research.

The MIND study is "the largest and longest of its kind, enrolling up to 300 people in 23 states to see if a nicotine patch, developed to help smokers kick the habit, can also help sharpen memory and attention". NBC4 Washington recently featured the study.

To learn more about how you can leverage the TIN for your multicenter trial or to even become a site investigator on a trial utilizing the TIN, please visit our GHUCCTS TIN page.

Related News

TBS Grant Writing Workshop (GWW) Series registration is now open for the 2021-2022 cycle.

Sep 08, 2021

Georgetown-Howard Universities Center for Clinical and Translational Science (GHUCCTS) Translational Biomedical Science (TBS) Program is offering a 6 month Grant Writing Workshop Series

GHUCCTS announces 2021 KL2 Scholars Dr. Maurice Fluitt & Dr. Roxanne Mirabal-Beltran

Aug 10, 2021

After our 11th highly competitive application cycle, unfortunately delayed due to COVID-related research closures, the Georgetown-Howard Universities Center for Clinical and Translational Science (GHUCCTS) is pleased to announce the appointment of Dr. Maurice Fluitt and Dr. Roxanne Mirabal-Beltran as a KL2 Scholar.

GHUCCTS featured in National Black Nurses Association for Howard University's Novavax COVID-19 Clinical Trial

May 28, 2021

GHUCCTS is featured in the Winter 2021 edition of the National Black Nurses Association (NBNA) Newsletter for our work helping with the planning, recruitment, and implementation efforts of the Novavax COVID-19 vaccine study at Howard University.

Close